Deciphera Pharmaceuticals
A clinical-stage biopharmaceutical company focused on improving the lives of cancer patients by tackling key mechanisms of drug resistance that limit the effectiveness of many cancer therapies.
HQ location
Waltham, United States
Website
Launch date
Employees
Market cap
$2.2b
Enterprise value
$2.0b
Share price
$25.59 DCPH
Recent deals
Authorizing premium user...